Nina D. Wagner-johnston, MD | Authors

Something Old, Something New: Options for Treating Relapsed Mantle Cell Lymphoma

July 17, 2009

Dr. Ruan and colleagues provide an excellent summary of available treatment options, as well as new drugs on the horizon, for the management of relapsed mantle cell lymphoma (MCL). As the authors emphasize, treatment of relapsed MCL is strongly influenced by the patient’s first-line therapy and needs to be individualized based on both patient and disease characteristics.